- Home
- AXR vs VXRT Comparison
AXR vs VXRT Comparison
Compare AXR & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXR
- VXRT
- Stock Information
- Founded
- AXR 1961
- VXRT N/A
- Country
- AXR United States
- VXRT United States
- Employees
- AXR N/A
- VXRT N/A
- Industry
- AXR Homebuilding
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AXR Real Estate
- VXRT Health Care
- Exchange
- AXR Nasdaq
- VXRT Nasdaq
- Market Cap
- AXR 203.2M
- VXRT 200.3M
- IPO Year
- AXR N/A
- VXRT N/A
- Fundamental
- Price
- AXR $32.78
- VXRT $0.74
- Analyst Decision
- AXR
- VXRT Strong Buy
- Analyst Count
- AXR 0
- VXRT 2
- Target Price
- AXR N/A
- VXRT $3.00
- AVG Volume (30 Days)
- AXR 34.8K
- VXRT 2.6M
- Earning Date
- AXR 03-07-2025
- VXRT 03-13-2025
- Dividend Yield
- AXR N/A
- VXRT N/A
- EPS Growth
- AXR N/A
- VXRT N/A
- EPS
- AXR 2.30
- VXRT N/A
- Revenue
- AXR $63,223,000.00
- VXRT $16,760,000.00
- Revenue This Year
- AXR N/A
- VXRT $128.43
- Revenue Next Year
- AXR N/A
- VXRT N/A
- P/E Ratio
- AXR $14.26
- VXRT N/A
- Revenue Growth
- AXR 54.34
- VXRT 303.27
- 52 Week Low
- AXR $15.88
- VXRT $0.52
- 52 Week High
- AXR $39.67
- VXRT $1.54
- Technical
- Relative Strength Index (RSI)
- AXR 54.89
- VXRT 52.85
- Support Level
- AXR $27.81
- VXRT $0.70
- Resistance Level
- AXR $32.10
- VXRT $0.83
- Average True Range (ATR)
- AXR 1.31
- VXRT 0.10
- MACD
- AXR 0.31
- VXRT -0.00
- Stochastic Oscillator
- AXR 80.29
- VXRT 36.84
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.